AXLRx Book a callCommission
Twenty minutes with a consultant, before anything is commissioned.Book a scoping call →

Module 03

Clinical Trial Analytics

Who is running which trials, at what phase, on which endpoints?

5 markets 72h to deliverable

Commission Clinical Trial Analytics See an example

What it answers

The questions this module is built to settle.

01Which sponsors are running trials in this indication, and at what phase?Every active and completed trial by sponsor, phase and status; Which programmes are closest to a readout
02Which endpoints are the trials built to win on?Primary and key secondary endpoints side by side; Where endpoint choice shapes the eventual label
03Where are the trials being run?Sites and investigators by country; Where trial activity signals future launch sequence

How the engine builds it

Method first. Then the evidence. Then the gate.

  1. Step 01Trial records are read from the registry by trial ID, never recalled
  2. Step 02Endpoints and phases are compared as registered, with the registry record cited on every row

What you receive

Working files, not a slide of prose.

Trial landscape workbook · PDF brief. Scope confirmed in 24 hours, delivered in 72.

Clinical Trial Analytics: questions buyers ask

What is a clinical trial landscape analysis?

It is a structured map of the trials in an indication: sponsors, phases, status, endpoints and sites, read from the registry by trial ID, so a team can see which programmes are closest to a readout and what each is built to win on.

Where does the trial data come from?

From the trial registries, read record by record by trial ID, and from the trials' primary publications where the registry does not name investigators.

Run Clinical Trial Analytics on your asset.

CommissionBook a scoping call